Total Payments
$19,565
2024 Payments
$117.76
Companies
11
Transactions
57
Medicare Patients
956
Medicare Billing
$97,187
Payment Breakdown by Category
Other$16,250 (83.1%)
Food & Beverage$1,791 (9.2%)
Travel$1,525 (7.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,250 | 9 | 83.1% |
| Food and Beverage | $1,791 | 45 | 9.2% |
| Travel and Lodging | $1,525 | 3 | 7.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $19,260 | 43 | $0 (2024) |
| Davol Inc. | $105.26 | 2 | $0 (2021) |
| Gilead Sciences, Inc. | $55.20 | 3 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $28.62 | 2 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $23.21 | 1 | $0 (2018) |
| Nestle HealthCare Nutrition Inc. | $20.44 | 1 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.98 | 1 | $0 (2024) |
| Celgene Corporation | $15.22 | 1 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $13.60 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $12.19 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $117.76 | 7 | Gilead Sciences, Inc. ($55.20) |
| 2023 | $168.85 | 6 | AbbVie Inc. ($155.25) |
| 2022 | $96.98 | 4 | ABBVIE INC. ($84.81) |
| 2021 | $172.47 | 6 | Davol Inc. ($105.26) |
| 2020 | $19.63 | 1 | AbbVie Inc. ($19.63) |
| 2019 | $40.81 | 3 | Intercept Pharmaceuticals, Inc. ($28.62) |
| 2018 | $11,918 | 14 | AbbVie, Inc. ($11,894) |
| 2017 | $7,031 | 16 | AbbVie, Inc. ($7,031) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.15 | General |
| 07/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.92 | General |
| 04/25/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.22 | General |
| Category: Neuroscience | ||||||
| 03/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.13 | General |
| 03/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: IMMUNOLOGY | ||||||
| 01/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/30/2023 | AbbVie Inc. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/21/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $2.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/16/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: VIROLOGY | ||||||
| 03/22/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/01/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.77 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2022 | Tactile Systems Technology Inc | Flexitouch Plus (Device), entre | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 02/28/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2021 | Davol Inc. | BD MAX (Device) | Food and Beverage | In-kind items and services | $66.38 | General |
| Category: Molecular Diagnostics | ||||||
| 05/25/2021 | Davol Inc. | Progel (Device) | Food and Beverage | In-kind items and services | $38.88 | General |
| Category: BD Interventional Surgery | ||||||
| 04/20/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: VIROLOGY | ||||||
| 04/07/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: VIROLOGY | ||||||
| 01/20/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/21/2020 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: VIROLOGY | ||||||
| 09/16/2019 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 496 | 537 | $484,091 | $51,994 |
| 2022 | 8 | 263 | 270 | $563,149 | $26,828 |
| 2021 | 4 | 75 | 87 | $26,875 | $7,394 |
| 2020 | 6 | 122 | 144 | $47,948 | $10,971 |
Total Patients
956
Total Services
1,038
Medicare Billing
$97,187
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $19,776 | $10,401 | 52.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 81 | 83 | $144,340 | $8,309 | 5.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 42 | 44 | $94,002 | $7,933 | 8.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 91 | 92 | $91,523 | $6,265 | 6.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 66 | $9,804 | $6,061 | 61.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 75 | $7,680 | $4,806 | 62.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 40 | $24,279 | $3,876 | 16.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 25 | 25 | $42,969 | $1,920 | 4.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 13 | 13 | $23,068 | $1,287 | 5.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $26,650 | $1,135 | 4.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 29 | 29 | $117,363 | $5,298 | 4.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 46 | 46 | $152,565 | $4,446 | 2.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 52 | 55 | $25,131 | $4,091 | 16.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 51 | 52 | $125,775 | $3,511 | 2.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 32 | 35 | $75,025 | $2,928 | 3.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $12,835 | $2,526 | 19.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 22 | $12,980 | $2,183 | 16.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $41,475 | $1,846 | 4.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 34 | $7,650 | $2,245 | 29.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $7,200 | $2,003 | 27.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 16 | $5,200 | $1,607 | 30.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 21 | 21 | $6,825 | $1,538 | 22.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 31 | 31 | $9,969 | $2,432 | 24.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 21 | 21 | $9,450 | $2,421 | 25.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 42 | $8,988 | $2,214 | 24.6% |
About Dr. Syed Rizvi, M.D
Dr. Syed Rizvi, M.D is a Gastroenterology healthcare provider based in Greenfield, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548376312.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Syed Rizvi, M.D has received a total of $19,565 in payments from pharmaceutical and medical device companies, with $117.76 received in 2024. These payments were reported across 57 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($16,250).
As a Medicare-enrolled provider, Rizvi has provided services to 956 Medicare beneficiaries, totaling 1,038 services with total Medicare billing of $97,187. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Greenfield, IN
- Active Since 08/22/2006
- Last Updated 02/14/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1548376312
Products in Payments
- Mavyret (Drug) $13,762
- Viekira (Drug) $1,707
- SKYRIZI (Biological) $202.56
- Creon (Drug) $105.97
- BD MAX (Device) $66.38
- MAVYRET (Drug) $51.84
- Progel (Device) $38.88
- HUMIRA (Biological) $37.71
- OCALIVA (Drug) $28.62
- RINVOQ (Biological) $24.98
- UPTRAVI (Drug) $23.21
- ZENPEP (Drug) $20.44
- EOHILIA (Drug) $19.98
- ZEPOSIA (Drug) $15.22
- CREON (Drug) $14.19
- REBYOTA (Biological) $13.60
- STELARA (Biological) $12.19
- Flexitouch Plus (Device) $12.17
- VIBERZI (Drug) $2.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.